Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Venezuelan Ministry of Mines Revokes Mineral Rights of Siembra Minera – Gold Reserve Considering All Legal Rights and Remedies
Venezuelan Ministry of Mines Revokes Mineral Rights of Siembra Minera – Gold Reserve Considering All Legal Rights and Remedies


Gold Reserve Inc. (TSX.V: GRZ) (OTCQX: GDRZF) (“Gold Reserve” or the “Company”) announced that it has learned that The Ministry of Mines of Bolivarian Republic of Venezuela (“Ministry of Mines”)

State Street to Develop Digital Custody in Collaboration with Copper.co
State Street to Develop Digital Custody in Collaboration with Copper.co


State Street Corporation (NYSE: STT) announced today that State Street Digital, the firm’s dedicated Digital division, has entered into a licensing agreement with Copper.co, a London-based provider

Pitney Bowes and Ambi Robotics Sign $23 Million Deployment Expansion To Help Optimize Last-Mile Sorting Across US Hubs
Pitney Bowes and Ambi Robotics Sign $23 Million Deployment Expansion To Help Optimize Last-Mile Sorting Across US Hubs


Pitney Bowes (NYSE: PBI), a global shipping and mailing company that provides technology, logistics, and financial services and Ambi Robotics, the leader in robotic sorting systems for supply chain

Philip Morris International Inc. (PMI) Suspends Investment and Activates Plans to Scale Down Manufacturing Operations in the Russian Federation
Philip Morris International Inc. (PMI) Suspends Investment and Activates Plans to Scale Down Manufacturing Operations in the Russian Federation


Regulatory News:



Philip Morris International Inc. (NYSE: PM) today announces the suspension of its planned investments in the Russian Federation, including all new product launches and

Alcoa Completes Energy Infrastructure Project at Its Deschambault Smelter in Canada to Boost Aluminum Production, Improve Stability
Alcoa Completes Energy Infrastructure Project at Its Deschambault Smelter in Canada to Boost Aluminum Production, Improve Stability


Alcoa Corporation (NYSE: AA) today officially marked the completion of a capital project that is expected to improve stability, increase efficiency, and boost production at its Deschambault

Cortexyme Announces Preclinical Data Highlighting Potential Therapeutic Benefits of Atuzaginstat for the Treatment of High-Risk Oral Potentially Malignant Disorders
Cortexyme Announces Preclinical Data Highlighting Potential Therapeutic Benefits of Atuzaginstat for the Treatment of High-Risk Oral Potentially Malignant Disorders


Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company pioneering upstream therapeutic approaches to improve the lives of patients diagnosed with degenerative diseases, today

IPA Updates on Investigational New Drug (IND) Enabling Program for PolyTope® TATX-03
IPA Updates on Investigational New Drug (IND) Enabling Program for PolyTope® TATX-03


IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company”) (NASDAQ: IPA) (TSXV: IPA) is pleased to report on the latest progress in the development of their PolyTope® TATX-03 antibody cocktail therapy

Savara to Present at Oppenheimer’s 32nd Annual Healthcare Conference
Savara to Present at Oppenheimer’s 32nd Annual Healthcare Conference


Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will present at Oppenheimer’s 32nd Annual

CleanGo Innovations Inc. Is Pleased ToReport That They Have CommencedDiscussions With An EstablishedGerman Distributor
CleanGo Innovations Inc. Is Pleased ToReport That They Have CommencedDiscussions With An EstablishedGerman Distributor
CleanGo Innovations Inc. Is Pleased ToReport That They Have CommencedDiscussions With An EstablishedGerman Distributor
Ozon Comments on its $750 million Senior Unsecured Convertible Bonds due 2026
Ozon Comments on its $750 million Senior Unsecured Convertible Bonds due 2026


Ozon Holdings PLC (NASDAQ and MOEX: “OZON”, thereafter referred to as “we,” “us,” “our,” “Ozon” or the “Company”), a leading Russian e-commerce platform, provides further update on the potential

REV Group, Inc. Reports First Quarter Results and Reaffirms Fiscal 2022 Outlook
REV Group, Inc. Reports First Quarter Results and Reaffirms Fiscal 2022 Outlook


REV Group, Inc. (NYSE: REVG), a manufacturer of industry-leading specialty vehicles, today reported results for the three months ended January 31, 2022 (“first quarter 2022”). Consolidated net

Deciphera Pharmaceuticals, Inc. to Present at the Barclays Global Healthcare Conference
Deciphera Pharmaceuticals, Inc. to Present at the Barclays Global Healthcare Conference


Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that Tucker Kelly, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Barclays Global

IMV to Showcase its DPX® Delivery Technology in Two Presentations at the AACR Annual Meeting 2022
IMV to Showcase its DPX® Delivery Technology in Two Presentations at the AACR Annual Meeting 2022


IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immune-educating therapies based on its novel DPX platform to treat solid and hematologic cancers, today

Biomind Labs Receives Approval for a Second Phase II Clinical Trial for Treatment-resistant Depression
Biomind Labs Receives Approval for a Second Phase II Clinical Trial for Treatment-resistant Depression


Biomind Labs Inc. (“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: CRSWF) (FSE: 3XI), a leading biotech company focused on innovation and research on endogenous tryptamines (biomolecules acting

Form 8.3 - The Vanguard Group, Inc.: NortonLifeLock Inc.
Form 8.3 - The Vanguard Group, Inc.: NortonLifeLock Inc.
Form 8.3 - The Vanguard Group, Inc.: NortonLifeLock Inc.
Pfizer Initiates Phase 2/3 Study of Novel COVID-19 Oral Treatment in Pediatric Participants
Pfizer Initiates Phase 2/3 Study of Novel COVID-19 Oral Treatment in Pediatric Participants


Pfizer Inc. (NYSE: PFE) announced today that it has initiated a Phase 2/3 study, EPIC-PEDS (Evaluation of Protease Inhibition for COVID-19 in Pediatric Patients), to evaluate the safety

DGAP-Adhoc: GRAMMER Aktiengesellschaft: Supervisory Board members Alfred Weber and Dr. Peter Merten resign their mandats at the end of the Annual General Meeting
DGAP-Adhoc: GRAMMER Aktiengesellschaft: Supervisory Board members Alfred Weber and Dr. Peter Merten resign their mandats at the end of the Annual General Meeting
DGAP-Adhoc: GRAMMER Aktiengesellschaft: Supervisory Board members Alfred Weber and Dr. Peter Merten resign their mandats at the end of the Annual General Meeting
DGAP-News: Deutsche Post AG: Announcement pursuant to Art. 5 para 1 of Regulation (EU) No. 596/2014 in conjunction with Art. 2 para 1 of the Delegated Regulation (EU) 2016/1052 of the Commission
DGAP-News: Deutsche Post AG: Announcement pursuant to Art. 5 para 1 of Regulation (EU) No. 596/2014 in conjunction with Art. 2 para 1 of the Delegated Regulation (EU) 2016/1052 of the Commission
DGAP-News: Deutsche Post AG: Announcement pursuant to Art. 5 para 1 of Regulation (EU) No. 596/2014 in conjunction with Art. 2 para 1 of the Delegated Regulation (EU) 2016/1052 of the Commission
Lenovo Delivers Future-Ready IT Infrastructure for Midsize Companies
Lenovo Delivers Future-Ready IT Infrastructure for Midsize Companies


Today, Lenovo (HKSE: 992) (ADR: LNVGY) introduced newly customized IT infrastructure solutions for midsize businesses, with a complete series of easy-to-use solutions and services to help them

NICE CXone Gets Top Honors for Contact Center Platforms in Metrigy Research
NICE CXone Gets Top Honors for Contact Center Platforms in Metrigy Research


NICE (Nasdaq: NICE) today announced that it has been recognized as a MetriStar Top Provider in the Contact Center Platform category from among 16 companies evaluated. Based on a ranking of

Transgene to Present New Positive Preliminary Phase I Data on TG4050 (myvac® platform), its Individualized Therapeutic Cancer Vaccine, at AACR 2022
Transgene to Present New Positive Preliminary Phase I Data on TG4050 (myvac® platform), its Individualized Therapeutic Cancer Vaccine, at AACR 2022


Regulatory News:



Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer will be presenting a poster with

Transgene and BioInvent Announce Poster Presentation on BT-001, a Novel Antibody-encoding Oncolytic Virus, at AACR 2022
Transgene and BioInvent Announce Poster Presentation on BT-001, a Novel Antibody-encoding Oncolytic Virus, at AACR 2022


Regulatory News:



Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, and BioInvent International AB (“BioInvent”) (Nasdaq

DGAP-News: Continental Generates Profit and Expects Further Improvement in Results
DGAP-News: Continental Generates Profit and Expects Further Improvement in Results
DGAP-News: Continental Generates Profit and Expects Further Improvement in Results
DGAP-News: Nordex Group: preliminary annual figures for 2021 confirm guidance
DGAP-News: Nordex Group: preliminary annual figures for 2021 confirm guidance
DGAP-News: Nordex Group: preliminary annual figures for 2021 confirm guidance
Very successful financial year 2021
Very successful financial year 2021
Very successful financial year 2021